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Available online xxxxBackground: Although not yet recommended by the guidelines, distal radial access, a new site for cardiovascular
interventions, has been rapidly acknowledged and adopted bymany centers due to its high rate of success, safety
and fewer complications. We present our experience using secondary distal radial access during transcatheter
aortic valve implantation (TAVI), proposing a new, even more minimal approach.
Methods: As of November 2020, a systematic distal radial approach as secondary access site for TAVIwas adopted
in our center. Primary endpoints were technical success andmajor adverse events (MAEs). Secondary endpoints:
the access site complication rate, hemodynamic and clinical results of the intervention, procedural related factors,
crossover rate to the femoral access site, and hospitalization duration (in days).
Results: From November 2020, 41 patients underwent TAVI using this strategy. Patients had a mean age of 76 ±
11.2 years, 41%weremale. Six (14.63%) patients received a balloon-expandable valve and 35 (85.37%) received a
self-expandable valve. TAVI was successful in all cases. No complications occurred due to transradial access.
Puncture success, defined as completed sheath placementwasmaximum(N=41/41,100%) and emergent trans-
femoral secondary access was not required in any case. Primary transfemoral vascular access site complications
occurred in 7 cases (17%) of which 4 (13.63%) were resolved through distal radial access: one occlusion, two
flow-limiting stenoses and four perforations of the common femoral artery. There were no additional major vas-
cular complications at 30 days. Overall MACE rate was 2.4%.
Conclusion: The use of the distal radial approach for secondary access in TAVI is safe, feasible and has several ad-
vantages over old access sites.
© 2021 Published by Elsevier Inc.Keywords:
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borus, V. Sasi, et al., Distal rad
cularization Medicine, https:The transradial approach (TRA) as secondary access in TAVI has become
the preferred access site due to its significant reduction in (overall and
major) vascular and bleeding periprocedural events (approximately
25% of periprocedural access VCs are related to the transfemoral second-
ary access [1]). Distal radial access (dRA) at the anatomical snuffbox has
been reported [2–4] as a safe and feasible unique alternative to TRA at
thewrist [3]. The need for patent hemostasis with forearm radial access,
to minimize the risk of radial artery occlusion (RAO) mandates close
vigilance for bleeding to prevent forearm hematoma formation and re-
quires prompt effective management if it develops, to stop progression
to compartment syndrome. The latter riskmay be lowerwith dRA as not
only is the puncture site distal to the forearm, but it ismore readily com-
pressible. A typical complication of proximal radial access (pRA) is a
chronic RAO caused by local hematoma, spasm, arterial wall damage
or compression [4,5] and dRA was proven superior to proximal radial
access in preventing proximal RAO at 24 h and 30 days after a diagnostic
or interventional coronary procedure [6]; another important aspect isial secondary access for transcatheter aortic valve implantation: The
//doi.org/10.1016/j.carrev.2021.11.021
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dRA location is after the superficial palmar branch of the radial artery
(Fig. 1), therefore flow ismaintained through this branch and thrombus
formation is stopped at this point. Lastly, hand position difficulties take
place more often when performing pRA.
Putting forward these advantages, dRA competes with the conven-
tional radial approach and may change our common access common
in the near future. Several registries have been collected recently re-
garding dRA for coronary angiography and interventions [7–10] but
there are no data regarding dRA as a secondary site for TAVI, although
it may bring significant benefit in terms of VC reduction and patient-
operator ergonomics. We aimed to prospectively analyze the proce-
dural performance, outcomes, safety and efficacy of dRA as a new,
minimalistic option during TAVI.
2. Methods
Clinical and angiographic data from 41 consecutive patients with se-
vere, symptomatic aortic stenosis (AoS) were evaluated in a retrospec-
tive single-center study. Between November 2020 and April 2021 the
patients were treated using dual access, one distal-radial and one femo-
ral. Distal radial access was obtained using a 5 or 6 French Glidesheath
(Terumo Medical Corporation, Somerset, NJ, USA). When 2 secondary
access sites were needed (for periprocedural coronary protection),
both distal radial arteries were cannulated. Access to the ascending
aorta from the radial artery was typically obtained using a 5F pigtail
on a 0.35″ guidewire (J-Tip Guidewire, Terumo Medical Corporation,
Somerset, New Jersey, USA). Transfemoral TAVI cases were routinely
performed under local and general anesthetic with transesophageal
echocardiographic guidance unless clinical reasons required otherwise.
Portico (St Jude Medical, MN, USA), Evolut (Medtronic, Inc., Minneapo-
lis, Minn, USA), Acurate (Boston Scientific, Boston, MA, USA) and
Myvalve (Meril Life Sciences Pvt. Ltd., Vapi, Gujarat, India) valves were
used. TF primary access closure was performed with one ProGlide de-
vice (Abbott Vascular, Santa Clara, CA, USA) and one AngioSeal 8F
(TerumoMedical Corporation, Somerset, NJ, USA). Our Insitutional Eth-
ical Review Committee approved the study (OGYÉI/50275/2017), and
all patients provided written informed consent prior to study inclusion.
2.1. Inclusion criteria
We included high risk patients with symptomatic significant AoS in
the study after written informed consent was obtained.Fig. 1. Curtesy of P. Patel et al. Distal radial artery course through the anatomic snuffbox.




(1) hemodynamic Preexisting aortic prosthesis, recent myocardial
infarction, left ventricular or atrial thrombus, severe aortic, mitral or tri-
cuspid regurgitation (grade III-IV), recent cerebrovascular event (within
3 months), carotid or vertebral arterial stenosis (>80%), active internal
bleeding, thrombocytopenia (platelet count<50,000/mm3), (2) ethical:
lack of written informed consent, severe mental disorder, drug/alcohol
addiction, life expectancy <1/2 year, participation in another drug or
device study, pregnancy, and (3) vascular: patients with occluded, se-
verely diseased or small (<1.5) mm radial or ulnar arteries on both
sides were not included.
Our primary endpoints were technical success and major adverse
events (MAEs). The secondary endpoints were the access site complica-
tion rate, hemodynamic and clinical results of the intervention, proce-
dural related factors, crossover rate, radial occlusion rate and hospitali-
zation duration (in days).
2.3. Definitions
Major adverse events (MAEs): MAEs were assessed as the composite
of death, stroke,myocardial infarction, and urgentmajor aortic valve re-
placement or implantation during the hospital stay and/or at the one-
month follow-up.
Definition of vascular complications: Major vascular complications
were defined as diminished or lost arterial pulse or the presence of
any pseudoaneurysm or arteriovenous fistula during the clinical
follow-up. Minor complications were defined as hematomas requiring
no further treatment (EASY 1–2), measuring 2 cm in diameter over
the radial or ulnar puncture area or measuring 5 cm in diameter over
the femoral puncture site. Major bleeding was defined as a drop in the
hemoglobin level of >3 g/dl, as well as any bleeding requiring blood
transfusions. Major hematoma was defined as EASY 3–4 hematoma.
Technical successwas defined as successful transcatheter aortic valve
implantation over the native, stenotic aortic valve.
Hemodynamic success was defined as a 90% drop in the mean aortic
gradient.
Clinical success: Primary clinical success was defined as an improve-
ment of at least one clinical category in the NYHA classification.
2.4. Duplex ultrasound (US) protocol
Duplex USwas used in the operating room to investigate all forearm
arteries. RA, UA diameter and peak systolic velocity were measured at
the wrist level. On the first postoperative day, all patients underwent
control duplex US.
Access site selection: Two skilled operators trained in bilateral trans-
radial access and TAVI performed all cases. The primary preferred access
site was the right femoral artery, and for aortography the left radial ar-
tery was used. The left radial artery was punctured distally, with the
arm flexed and pronated on the patient's abdomen, reproducing a nat-
ural positon, increasing the patient's comfort and minimizing operator
discomfort during the procedure (Fig. 2). The alternative access site
was the ulnar artery, which was used when a Doppler ultrasound
showed a small radial artery (less than 1.5 mm) or was extremely calci-
fied or occluded. For rapid pacing the access site was the femoral or the
jugular vein or guidewire pacing approach.
2.5. Statistical analysis
Statistical analysis was performed using commercially available
GraphPad Prism 8.0 software (USA). Continuous variables were
expressed as the mean ± standard deviation or as the median with in-
terquartile range. Categorical variables were tabulated as percentages.
The different patient cohorts were compared using either the Mann-
Fig. 2. Patient example, right femoral primary access (A) and left distal radial secondary access (B), both sheaths being in proximity of each other, enhancing better ergonomics and
lowering the radiation dose.
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0.05 were considered to be significant.
3. Results
The main baseline clinical and procedural characteristics of the
global population and according to the secondary approach (transfem-
oral versus transradial) are shown in Table 1.
TAVI was successful in all cases. Procedural details are highlighted in
Table 2. Technical success was achieved in all patients (100%). Clinical
success was achieved in 40 patients (97,5%). Hemodynamic success
was achieved in all patients (100%). By hemodynamic investigation,
the peak-to-peak mean gradient decreased from 76.8 ± 27.2 to
10.7 ± 5.1 mmHg (p = 0.001). Balloon postdilatation was performed
in 19 cases (46.3%), and the crossover to urgent surgical aortic valve im-
plantation was 0%. Secondary access was achieved through the left dRA
only (100%) and the crossover rate to the femoral access site was
achieved in 3 cases (7.31%) ofmajor primary femoral access perforation.
Temporary pacing was performed either through the jugular vein (n=
19, 46.3%) or femoral vein (n = 10, 24.3%) or directly on the TAVI stiff
wire (n = 12, 29.2%). The fluoroscopy time, X-ray dose, procedureTable 1
Demographic and clinical data.
n (%)
Demographic data Age (years) 76.0 ± 11.2
Male 17 (41)
Hypertension 34 (82.9)
Current smokers 11 (26.8)
Diabetes mellitus 15 (36.5)
IDDM 4 (9.7)
NIDDM 11 (26.8)
Weight (kg) 79.4 ± 16.7
Height (cm) 167.1 ± 9.9
COPD 9 (21.9)
Renal insufficiency 15 (36.5)
Family history 9 (21.9)
Dyslipidemia 26 (63.4)
Atrial fibrillation 17 (41.4)
Cardiac and vascular history Coronary artery disease 13 (31.7)
Peripheral artery disease 7 (17.07)
Previous PCI or coronary bypass 10 (24.3)
Previous valve surgery 3 (7.31)
Symptoms
- Angina 34 (82.9)
- Dyspnoea 41 (100)
- Syncope 2 (4.87)
3
time, and contrast consumption were 18.20 ± 7.6 min, 529.8 ±
484.6 mGy, 50.3 ± 28.1 min, and 64.9 ± 28.1 ml, respectively. Mean
hospitalization duration over the cohort was 4 ± 2.5 days. Ultrasonog-
raphy parameters before and after the procedure are summarized in
Table 2.
No complications occurred due to transradial access. Transfemoral
vascular access site complications occurred in 7 cases (17.07%): 1 occlu-
sion, 2flow-limiting stenoses and 4 perforations of the common femoral
artery. Three complications were successfully managed using balloon
dilatation and balloon tamponade from the transradial access (Fig. 3).
The cases of major perforation (9.75%) were successfully treated with
a covered stent delivered via direct ipsilateral superficial femoral retro-
grade 6F access and stent delivery with angiographic control from dRA
(Fig. 4). There were no additional major vascular complications at
30 days. Five cases of PCI (12.19%) and one case of left subclavian artery
PTA (2.43%)were successfully performed through dRA, in the same ses-
sion. Hemostasis of the primary transfemoral access was achieved per-
cutaneously (vs surgical cut-down) in all patients, using two ProGlide
devices (Abbott Vascular, Santa Clara, California) in 31.82% and one
ProGlide plus one Angioseal 8F device (Terumo Medical Corporation,




NYHA 1 0 1
NYHA 2 1 30
NYHA 3 30 10
NYHA 4 9 0
Vascular ultrasound (radial site)
- Radial artery (mm) 1.8 ± 0.5 1.8 ± 0.5
- Hematoma (EASY 1–2) 0 1
- Hematoma (EASY 3–4) 0 0
- Radial artery occlusion 0 0
- Pseudoaneurysm 0 0
Transthoracal ultrasound
LVEF
- 50–70% 34 (82.92) 37 (90.24)
- 30–50% 6 (14.63) 4 (9.75)
- <30% 1 (2.43) 0 (0)
Aortic gradient (peak) 76.8 ± 27.2 10.7 ± 5.1
Aortic gradient (mean) 50.9 ± 18.7 12.6 ± 9.3
AVA (mm2) 0,67 ± 0.13 2.4 ± 0.27
Aortic regurgitation
- 0–2 24 (58.5) 10 (24.39)
- 3–4 0 (0) 0 (0)
Fig. 3. Thrombotic subocclusion of femoral artery treated percutaneously.
A - Angiography via MPA guide catheter in the iliac artery, showing extensive thrombus and poor flow. B - Angiography showing restoration of distal flow following balloon dilatation.
Technical details: 7.5 F sheatless guiding catether, V18 0.14″ guidewire (Boston Scientific, Natick,MA, USA), Passeo 6× 40mmballoon (Biotronik AG, Buelach, Switzerland), 2min inflation
at 8 atm.
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(48.7%), 19 (46.3%) and 2 (4.87%) patients, respectively. Hemostasis of
the radial accesswas achieved via compression in all cases, using a com-
bination of one StatSeal Disc (Biolife, LLC, USA)with gauze compression.
Standard hemostasis timewas 3 h. Theneed of repeating thehemostasis
was not needed in any cases. Data regarding radial occlusion were col-
lected 24 h after puncture and Doppler ultrasound revealed no artery
occlusion. All-cause 30-day mortality was 2.4% %, one patient suffered
esophageal and tracheal bleeding after extubation with hemorrhagic
shock (autopsy report revealed bleeding from the esophageal vein).
No stroke or myocardial infarction was observed.
4. Discussion
Our case series shows that TAVI can be performed safely using dRA
secondary access with no increase in radiation dose, screening time or
procedural duration. The occlusion rate proved to be non-existent.
This is of particular importance in order to keep access available. We
also show that with appropriate equipment major vascular complica-
tions related to femoral primary access can be managed entirely via
the TR approach (Fig. 3).
TRA for TAVI secondary access sites has been introduced to guide valve
implantation, to treat coronary lesions, and to control or treat vascular
access site complications. Coronary angioplasties, even complexs such
as LM-stenting could be simply and elegantly completed using dRA.
Puncturing the left dRA brings the left hand very close to the primaryFig. 4. Stent graft placement from direct femoral access route.
Balloon tamponade via dRA route (A), with unsuccessful hemostasis and active bleeding (B, arro
with subsequent deep femoral artery occlusion (C).
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femoral access, thus keeping the radiation dose low and enhancing
the comfort of the operator. Easy closure shortens the procedural time
and keeps the pRA available for emergency second-look at any time. A
total of 13.63% of our patients necessitated pre- or post-PCI during
TAVI, which was performed via dRA only. It has been reported that up
to a quarter of vascular complications during TAVI result from the use
of femoral secondary arterial access [1]. The introduction of TRA for cor-
onary angiography and angioplasty has reduced bleeding and access
site complications in coronary interventions [11]. Logically, the same
may be true during TAVI procedures, especially as the elderly patient co-
hort currently eligible for TAVI is at high risk of developing femoral ar-
terial complications. Because old and frail adults often presentwith lim-
ited arm motion, our approach demonstrated greater patient tolerabil-
ity and resulted in short hospital stays. Additionally, the procedural
time was shorter than that in other reports [1,12].
Transradial secondary access readily allows aortography to guide
valve implantation. For non-TF TAVI cases, this is the sole purpose of
secondary arterial access and thus TR access can be considered the de-
fault approach. Changing from conventional pRA to dRA, thus heading
toward an evenmore minimally invasive approach, can achieve further
VC reduction and longer radial lumen patency for possible future inter-
ventions. Various small observational studies have shown similar radia-
tion doses between pRA and dRAon coronary interventions [6,9,10], be-
cause the two access sites are very close to each other. However, we be-
lieve this concept could be different in TAVI, as in this case the operator
could receive the “femoral” radiation dose, lower than the radial dose,w) and final stent graft implantation over the common and superficial right femoral artery,
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Kim et al. recently described a novel technique using only a single arte-
rial access technique [12] (valve deployment without contrast injection
but using a guidingwire for valve positioning that is introduced through
the same femoral access but outside the large bore sheath), heading for
the sameminimalistic approach and stating that secondary access com-
plications were eliminated together with the whole secondary access
concept but we believe aortography is necessary for the valve position-
ing and further postdilatation decisions or ad-hoc PCI; therefore, sec-
ondary access should be kept and dRAmay be the solution for minimiz-
ing all possible secondary access complications.
dRA for coronary angioplasty is becoming the primary access site in
many catheterization laboratories. The main advantage of this access
site is the low rate of radial artery occlusion and the better comfort for
the patient during left transradial cases [3–10]. The main disadvantage
of this access site is the small size of the RA in this location, the
angulated course of the RA and the need of ultrasonography for the
puncture. It is essential to know that the dRA diameter is 80% less
than the proximal diameter, which may affect suitable French sheaths
that can be used, and it varies according to sex, race, and other factors.
The diameter of the dRA in females tends to be smaller than that in
males. Some studies have shown that hypertensive patients have larger
radial artery diameters than normal patients. Other studies show that
the diameter of dRA is positively correlated with both body weight
and basalmetabolic index. Ulnar arteries were slightly larger than radial
arteries and may be used as an alternative to dRA [8,13,14]. We did not
find a correlation between body weight and vessel diameter in our
group. A blind puncture increases the risk of tendon damage. At the
same time, the double-wall technique can irritate the underlying peri-
osteum and increase the risk of hematoma formation. Ultrasound (US)
allows the identification of anatomical landmarks, and enables accurate
vessel access, especially in impalpable dRA. The probe can be used to
perform a compressibility test to confirm that the target vessel corre-
sponds to the radial artery rather than the cephalic vein. Accurate scan-
ning can identify the superficial branch of the radial nerve, thus
avoiding potential injury. A further benefit of US guidance is that the op-
erator can measure the vessel size before puncturing. A vessel diameter
under 2.0mmwas associatedwith higher occlusion rate, spasm and pa-
tient pain [13,14,15]. The success rate of sheath placementwas found to
be 100% (41/41),without differences between the side (left dRA or right
dRA) or site (anatomical snuffbox or distal dorsal of the tendon of the
extensor pollicis longus) of the dRA. However, we must admit that an
adequately powered randomized trial is necessary to confirm this suc-
cess rate, as our study was a single-center study; moreover, it was a rel-
atively small study and we did not include acute, unstable patients re-
quiring emergency TAVI.
dRA for iliac and femoral angioplasty has been published recently
with high technical success and a very low complication rate [16]. Our
center is a dedicated dRA center; thus most of our operators are trained
to perform this puncture procedure. The limitation of the dRA for the
treatment of access site complications is the distance between the dRA
and the common femoral artery, therefore small bleedings or dissec-
tions can be treated from this access sitewith available devices (sheaths,
balloons, stents) (Fig. 3), but perforations need distal access if stent graft
implantation is needed. In this case series, stent graft placement was
needed in two cases and both were implanted from direct superficial
femoral artery access (Fig. 4). Spasm was infrequent because of the
use of a long transradial slender sheath, althoughwe did not administer
any intraarterial nitroglycerine due to aortic stenosis.
4.1. Limitations
This registry included neither a randomization nor a control group
and althoughwe used uniformly prespecified endpoints for the analysis
it was a retrospective data collection. It is therefore possible that some
patients with complications or crossover may have been overlooked.5
We tried to counter this problem by double rechecking all cath lab pro-
tocols in the participating centers during the period of data acquisition.
The lack of a control group with proximal access certainly limits our
conclusions; our goal was to implement this promising new access
site in other cardiac interventions. Additionally, no data were collected
regarding the occurrence of radial occlusion. Although this is usually a
silent complication with no clinical consequences, future studies will
have to evaluate the impact of this complication in the TAVI population.
More and more positive data on (left) distal radial access are being
published [10–17]. In fairness, the more publications appear, the more
local complications will be described as well. Simultaneously, many of
the benefits associatedwith distal access are becoming less and less the-
oretical at this point of time and as more practitioners adopt this tech-
nique, new nuances, indications, and technical aspects will assuredly
continue to emerge.
5. Conclusion
The initial results of this novel, minimalistic approach demonstrate
its feasibility and potential beneficial effects without compromising
procedural safety. The main advantages are less arterial obstruction
and short hemostasis. Larger randomized trials are needed to further
evaluate the advantages of dRA over pRA.
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